This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 Jan;25(2):99-100.

doi: 10.1016/j.ehj.2003.11.001.

Progress with diabetic patients undergoing percutaneous coronary intervention

PMID: 14720523
DOI: 10.1016/j.ehj.2003.11.001

Editorial

Progress with diabetic patients undergoing percutaneous coronary intervention

Marc Cohen. Eur Heart J. 2004 Jan.

. 2004 Jan;25(2):99-100.

doi: 10.1016/j.ehj.2003.11.001.

Author

PMID: 14720523
DOI: 10.1016/j.ehj.2003.11.001

No abstract available

PubMed Disclaimer

Comment on

Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial.
Abizaid A, Costa MA, Blanchard D, Albertal M, Eltchaninoff H, Guagliumi G, Geert-Jan L, Abizaid AS, Sousa AG, Wuelfert E, Wietze L, Sousa JE, Serruys PW, Morice MC; Ravel Investigators. Abizaid A, et al. Eur Heart J. 2004 Jan;25(2):107-12. doi: 10.1016/j.ehj.2003.11.002. Eur Heart J. 2004. PMID: 14720526 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems